BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35906151)

  • 1. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of Pancreatic Ductal Adenocarcinoma.
    He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
    Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
    Bian Y; Guo S; Jiang H; Gao S; Shao C; Cao K; Fang X; Li J; Wang L; Ma C; Zheng J; Jin G; Lu J
    Cancer Imaging; 2022 Jan; 22(1):4. PubMed ID: 34991733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.
    He M; Liu Z; Lin Y; Wan J; Li J; Xu K; Wang Y; Jin Z; Tian J; Xue H
    Eur J Radiol; 2019 Aug; 117():102-111. PubMed ID: 31307634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical-radiomics nomogram based on dual-layer spectral detector CT to predict cancer stage in pancreatic ductal adenocarcinoma.
    Wu L; Cen C; Yue X; Chen L; Wu H; Yang M; Lu Y; Ma L; Li X; Wu H; Zheng C; Han P
    Cancer Imaging; 2024 May; 24(1):55. PubMed ID: 38725034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
    Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
    Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
    Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
    Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CT Radiomics-Based Risk Score for Preoperative Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma.
    Zhou Y; Wang J; Zhang SL; Wang H; Yan Y; Qi X; Chen S; Chen FM
    Ann Surg Oncol; 2023 Feb; 30(2):1206-1216. PubMed ID: 36264518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a CT radiomics nomogram for preoperative prediction of Ki-67 index in pancreatic ductal adenocarcinoma: a two-center retrospective study.
    Li Q; Song Z; Li X; Zhang D; Yu J; Li Z; Huang J; Su K; Liu Q; Zhang X; Tang Z
    Eur Radiol; 2023 Nov; ():. PubMed ID: 37938382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
    Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
    Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
    Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
    Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative evaluating early recurrence in resectable pancreatic ductal adenocarcinoma by using CT radiomics.
    Wang G; Lei W; Duan S; Cao A; Shi H
    Abdom Radiol (NY); 2024 Feb; 49(2):484-491. PubMed ID: 37955726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
    Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
    Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
    Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
    World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
    Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
    Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.
    Shi Z; Ma C; Huang X; Cao D
    J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.
    Liu P; Gu Q; Hu X; Tan X; Liu J; Xie A; Huang F
    J Xray Sci Technol; 2020; 28(6):1113-1121. PubMed ID: 33074215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade.
    Tikhonova VS; Karmazanovsky GG; Kondratyev EV; Gruzdev IS; Mikhaylyuk KA; Sinelnikov MY; Revishvili AS
    Eur Radiol; 2023 Feb; 33(2):1152-1161. PubMed ID: 35986774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
    Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
    Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Ductal Adenocarcinoma at CT: A Combined Nomogram Model to Preoperatively Predict Cancer Stage and Survival Outcome.
    Cen C; Liu L; Li X; Wu A; Liu H; Wang X; Wu H; Wang C; Han P; Wang S
    Front Oncol; 2021; 11():594510. PubMed ID: 34109107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.